← Leaderboards
Richard Andrew Burkhart
Johns Hopkins University
$1,313,615
Attributed
$1,313,615
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.7K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,313,615 · 1
By mechanism
K08$1,313,615 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Harry C. Dietz$10,377,475
- Viswanathan Natarajan$24,234,784
- Elizabeth Marion Jaffee$29,780,612
- Mark Donowitz$42,405,980
- Jacques Ravel$18,661,935
Others in their field
Other Emerging Leaders on “Clinical Treatment”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$324,392,296
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$187,240,124
- Beth Baseler · Leidos Biomedical Research, Inc.$158,728,629
Research focus
Clinical TreatmentAftercareAdvanced DiseaseAdvisory CommitteesBasic ScienceBiological MarkersBiologyAwardCancer BiologyCancer CareCancer CenterCancer EtiologyCareer DevelopmentCaringCell LineCessation Of LifeChemotherapyBiopsyClinicClinically ActionableClinically RelevantClinical OncologyClinical ResearchClinical Trials
Grant awards (5)
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine$262,723
K08 · FY2024 · CA · contact PI
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine$262,723
K08 · FY2023 · CA · contact PI
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine$262,723
K08 · FY2022 · CA · contact PI
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine$262,723
K08 · FY2021 · CA · contact PI
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine$262,723
K08 · FY2020 · CA · contact PI